

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.64107236 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.37253042 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.29757487 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.26489913 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.13322441 |
| 6 | nucleobase catabolic process (GO:0046113) | 4.04281824 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.04012102 |
| 8 | locomotory exploration behavior (GO:0035641) | 4.03969145 |
| 9 | neuron cell-cell adhesion (GO:0007158) | 3.93991809 |
| 10 | neuronal action potential propagation (GO:0019227) | 3.81633540 |
| 11 | glutamate secretion (GO:0014047) | 3.81125703 |
| 12 | vocalization behavior (GO:0071625) | 3.76495790 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 3.61304829 |
| 14 | layer formation in cerebral cortex (GO:0021819) | 3.59281666 |
| 15 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.51907212 |
| 16 | neuron recognition (GO:0008038) | 3.49898032 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.49457166 |
| 18 | positive regulation of mitochondrial fission (GO:0090141) | 3.47271563 |
| 19 | protein localization to synapse (GO:0035418) | 3.43464107 |
| 20 | exploration behavior (GO:0035640) | 3.43161424 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.34279300 |
| 22 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.31241452 |
| 23 | axonal fasciculation (GO:0007413) | 3.20387481 |
| 24 | neurotransmitter secretion (GO:0007269) | 3.17054116 |
| 25 | dendritic spine morphogenesis (GO:0060997) | 3.16443858 |
| 26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.16417557 |
| 27 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.15815043 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 3.13821346 |
| 29 | activation of protein kinase A activity (GO:0034199) | 3.12880278 |
| 30 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.05787661 |
| 31 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05779618 |
| 32 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.05413332 |
| 33 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.04895252 |
| 34 | glycosphingolipid biosynthetic process (GO:0006688) | 3.03135300 |
| 35 | detection of calcium ion (GO:0005513) | 3.02170230 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 3.02052018 |
| 37 | presynaptic membrane assembly (GO:0097105) | 3.00885631 |
| 38 | cellular potassium ion homeostasis (GO:0030007) | 2.97466956 |
| 39 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.95518953 |
| 40 | mating behavior (GO:0007617) | 2.94566453 |
| 41 | transmission of nerve impulse (GO:0019226) | 2.93511427 |
| 42 | neuron-neuron synaptic transmission (GO:0007270) | 2.93049748 |
| 43 | membrane budding (GO:0006900) | 2.92845221 |
| 44 | response to dietary excess (GO:0002021) | 2.91247502 |
| 45 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.88229581 |
| 46 | protein localization to cilium (GO:0061512) | 2.87185420 |
| 47 | synaptic transmission, glutamatergic (GO:0035249) | 2.86892360 |
| 48 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.86536448 |
| 49 | vesicle transport along microtubule (GO:0047496) | 2.86372181 |
| 50 | proline transport (GO:0015824) | 2.84853719 |
| 51 | dendrite morphogenesis (GO:0048813) | 2.84852654 |
| 52 | innervation (GO:0060384) | 2.80860047 |
| 53 | establishment of mitochondrion localization (GO:0051654) | 2.78430212 |
| 54 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.77727620 |
| 55 | regulation of vesicle fusion (GO:0031338) | 2.76750220 |
| 56 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.75624749 |
| 57 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.74983278 |
| 58 | presynaptic membrane organization (GO:0097090) | 2.73642274 |
| 59 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.73524952 |
| 60 | long-term synaptic potentiation (GO:0060291) | 2.73312186 |
| 61 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.73291700 |
| 62 | L-serine transport (GO:0015825) | 2.71104169 |
| 63 | neurotransmitter transport (GO:0006836) | 2.71027250 |
| 64 | positive regulation of synapse assembly (GO:0051965) | 2.70830394 |
| 65 | organelle transport along microtubule (GO:0072384) | 2.69265436 |
| 66 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.69105528 |
| 67 | cerebellar Purkinje cell layer development (GO:0021680) | 2.67539742 |
| 68 | long-term memory (GO:0007616) | 2.66273551 |
| 69 | regulation of postsynaptic membrane potential (GO:0060078) | 2.65717636 |
| 70 | regulation of cell communication by electrical coupling (GO:0010649) | 2.63762190 |
| 71 | protein targeting to Golgi (GO:0000042) | 2.62008556 |
| 72 | postsynaptic membrane organization (GO:0001941) | 2.61794968 |
| 73 | positive regulation of membrane potential (GO:0045838) | 2.61791740 |
| 74 | auditory behavior (GO:0031223) | 2.61389512 |
| 75 | negative regulation of neurotransmitter transport (GO:0051589) | 2.61290939 |
| 76 | suckling behavior (GO:0001967) | 2.60756027 |
| 77 | regulation of synaptic plasticity (GO:0048167) | 2.60490055 |
| 78 | regulation of synapse assembly (GO:0051963) | 2.59543816 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 2.58005916 |
| 80 | synapse organization (GO:0050808) | 2.56308236 |
| 81 | positive regulation of potassium ion transport (GO:0043268) | 2.55906419 |
| 82 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.55396802 |
| 83 | short-term memory (GO:0007614) | 2.54618435 |
| 84 | chemosensory behavior (GO:0007635) | 2.54263482 |
| 85 | dendritic spine organization (GO:0097061) | 2.53003604 |
| 86 | synapse assembly (GO:0007416) | 2.51926390 |
| 87 | cell communication by electrical coupling (GO:0010644) | 2.51802307 |
| 88 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.51521432 |
| 89 | establishment of vesicle localization (GO:0051650) | 2.51482212 |
| 90 | Golgi transport vesicle coating (GO:0048200) | 2.50237282 |
| 91 | COPI coating of Golgi vesicle (GO:0048205) | 2.50237282 |
| 92 | lipid particle organization (GO:0034389) | 2.50082711 |
| 93 | regulation of neurotransmitter secretion (GO:0046928) | 2.49961163 |
| 94 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.48204721 |
| 95 | neuronal ion channel clustering (GO:0045161) | 2.48071306 |
| 96 | regulation of neurotransmitter levels (GO:0001505) | 2.46964474 |
| 97 | protein maturation by protein folding (GO:0022417) | 2.46622405 |
| 98 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.46288754 |
| 99 | establishment of melanosome localization (GO:0032401) | 2.44331801 |
| 100 | axon extension (GO:0048675) | 2.44233988 |
| 101 | sodium ion export (GO:0071436) | 2.43791435 |
| 102 | cerebellar granule cell differentiation (GO:0021707) | 2.43693226 |
| 103 | fear response (GO:0042596) | 2.43540349 |
| 104 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.43536531 |
| 105 | synaptic vesicle endocytosis (GO:0048488) | 2.43412040 |
| 106 | endoplasmic reticulum organization (GO:0007029) | 2.42408839 |
| 107 | membrane repolarization during action potential (GO:0086011) | 2.41539656 |
| 108 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.41330543 |
| 109 | membrane repolarization (GO:0086009) | 2.41159550 |
| 110 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.40599084 |
| 111 | regulation of dendritic spine development (GO:0060998) | 2.40456714 |
| 112 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.39895718 |
| 113 | neuron remodeling (GO:0016322) | 2.39147522 |
| 114 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.39100858 |
| 115 | neurofilament cytoskeleton organization (GO:0060052) | 2.38985937 |
| 116 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.38673590 |
| 117 | behavioral fear response (GO:0001662) | 2.38006575 |
| 118 | behavioral defense response (GO:0002209) | 2.38006575 |
| 119 | establishment of synaptic vesicle localization (GO:0097480) | 2.37646426 |
| 120 | synaptic vesicle transport (GO:0048489) | 2.37646426 |
| 121 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.37537920 |
| 122 | melanosome transport (GO:0032402) | 2.37398790 |
| 123 | regulation of feeding behavior (GO:0060259) | 2.36611825 |
| 124 | behavioral response to cocaine (GO:0048148) | 2.36489002 |
| 125 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.33577325 |
| 126 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.33504953 |
| 127 | establishment of protein localization to Golgi (GO:0072600) | 2.33263181 |
| 128 | inner ear receptor cell development (GO:0060119) | 2.33216173 |
| 129 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.31276855 |
| 130 | membrane depolarization (GO:0051899) | 2.31017144 |
| 131 | long term synaptic depression (GO:0060292) | 2.30608516 |
| 132 | peroxisome fission (GO:0016559) | 2.29764111 |
| 133 | heart contraction (GO:0060047) | 2.29700624 |
| 134 | heart process (GO:0003015) | 2.29700624 |
| 135 | response to auditory stimulus (GO:0010996) | 2.29571417 |
| 136 | establishment of pigment granule localization (GO:0051905) | 2.29161993 |
| 137 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.28757759 |
| 138 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.28757759 |
| 139 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.28207733 |
| 140 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.26031637 |
| 141 | negative regulation of microtubule polymerization (GO:0031115) | 2.25253386 |
| 142 | regulation of mitochondrial fission (GO:0090140) | 2.23159323 |
| 143 | retinal ganglion cell axon guidance (GO:0031290) | 2.21898958 |
| 144 | pigment granule transport (GO:0051904) | 2.21854582 |
| 145 | transferrin transport (GO:0033572) | 2.21334423 |
| 146 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.20350664 |
| 147 | neuron projection extension (GO:1990138) | 2.20099141 |
| 148 | ribonucleoprotein complex disassembly (GO:0032988) | 2.19611082 |
| 149 | homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156) | 2.19526076 |
| 150 | acidic amino acid transport (GO:0015800) | 2.19309697 |
| 151 | substantia nigra development (GO:0021762) | 2.18449149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.03174796 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.08955163 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.89514581 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88257849 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.75953370 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.51464069 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.51464069 |
| 8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50485005 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48585544 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41249807 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.40345029 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36570923 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.31975347 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.31753325 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19566285 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.09904598 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02135543 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.01773974 |
| 19 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.95940334 |
| 20 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.88883537 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.88830781 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84439571 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84411528 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81452053 |
| 25 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80244784 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.76509763 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68735088 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64830070 |
| 29 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.63307578 |
| 30 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.61274776 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56307851 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55231355 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.55178554 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54198695 |
| 35 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47837131 |
| 36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46229785 |
| 37 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45627796 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.44921455 |
| 39 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42622825 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41187246 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40515797 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38449517 |
| 43 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38299646 |
| 44 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35402512 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35012386 |
| 46 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34540451 |
| 47 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.33181965 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.30827769 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.30099367 |
| 50 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.29953781 |
| 51 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29437377 |
| 52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27795953 |
| 53 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.27199850 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.27104932 |
| 55 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25213648 |
| 56 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.24896082 |
| 57 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24481263 |
| 58 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24232356 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24167738 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24060638 |
| 61 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.23265279 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.21457185 |
| 63 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.21272716 |
| 64 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20926594 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19372710 |
| 66 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18861919 |
| 67 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18691178 |
| 68 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.18113339 |
| 69 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.17912834 |
| 70 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.17875785 |
| 71 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17302211 |
| 72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16875792 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16874558 |
| 74 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16654993 |
| 75 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15401687 |
| 76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.14929905 |
| 77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.14929905 |
| 78 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14872563 |
| 79 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14513000 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14513000 |
| 81 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14054886 |
| 82 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.13771891 |
| 83 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.13621260 |
| 84 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.13058047 |
| 85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.12678132 |
| 86 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12648716 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12551352 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12510700 |
| 89 | JUN_21703547_ChIP-Seq_K562_Human | 1.12384923 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10527867 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09398128 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08339411 |
| 93 | * KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07790115 |
| 94 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06853454 |
| 95 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06766266 |
| 96 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06468358 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05698307 |
| 98 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05309836 |
| 99 | AR_19668381_ChIP-Seq_PC3_Human | 1.03924489 |
| 100 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.03863182 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03345197 |
| 102 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02434758 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01649258 |
| 104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01010576 |
| 105 | EWS_26573619_Chip-Seq_HEK293_Human | 1.00819829 |
| 106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00661666 |
| 107 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00445681 |
| 108 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99852127 |
| 109 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99493274 |
| 110 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.99355610 |
| 111 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97751643 |
| 112 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97457815 |
| 113 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.97300081 |
| 114 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96070435 |
| 115 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95488708 |
| 116 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91144529 |
| 117 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90974272 |
| 118 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90420019 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90214416 |
| 120 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89203122 |
| 121 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.87896700 |
| 122 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86911732 |
| 123 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86702332 |
| 124 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86681121 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86202496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.83976798 |
| 2 | MP0003880_abnormal_central_pattern | 4.50183034 |
| 3 | MP0004270_analgesia | 3.69276123 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.40075660 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 2.81304698 |
| 6 | MP0002063_abnormal_learning/memory/cond | 2.66945207 |
| 7 | MP0009745_abnormal_behavioral_response | 2.64763510 |
| 8 | MP0002064_seizures | 2.52107305 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.43919395 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.36120027 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.29243070 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.23915618 |
| 13 | MP0002272_abnormal_nervous_system | 2.19545118 |
| 14 | MP0003329_amyloid_beta_deposits | 2.14410474 |
| 15 | MP0002837_dystrophic_cardiac_calcinosis | 2.06968657 |
| 16 | MP0009046_muscle_twitch | 2.06929894 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.02223525 |
| 18 | MP0000013_abnormal_adipose_tissue | 1.97892362 |
| 19 | MP0001440_abnormal_grooming_behavior | 1.92418141 |
| 20 | MP0001486_abnormal_startle_reflex | 1.91863315 |
| 21 | MP0001501_abnormal_sleep_pattern | 1.86546432 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.84474375 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 1.71582392 |
| 24 | MP0000778_abnormal_nervous_system | 1.69404055 |
| 25 | MP0002736_abnormal_nociception_after | 1.69352536 |
| 26 | MP0002735_abnormal_chemical_nociception | 1.69224620 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.68335442 |
| 28 | MP0001970_abnormal_pain_threshold | 1.68083689 |
| 29 | MP0005423_abnormal_somatic_nervous | 1.67098614 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.67031002 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.62077720 |
| 32 | MP0002184_abnormal_innervation | 1.60319917 |
| 33 | MP0004924_abnormal_behavior | 1.54287764 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.54287764 |
| 35 | MP0003122_maternal_imprinting | 1.53744493 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.51494860 |
| 37 | MP0000751_myopathy | 1.49683129 |
| 38 | MP0004858_abnormal_nervous_system | 1.46643606 |
| 39 | MP0002102_abnormal_ear_morphology | 1.46430428 |
| 40 | MP0003283_abnormal_digestive_organ | 1.46283729 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.45614455 |
| 42 | MP0004043_abnormal_pH_regulation | 1.43248033 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.42033576 |
| 44 | MP0008569_lethality_at_weaning | 1.37991456 |
| 45 | MP0000955_abnormal_spinal_cord | 1.36744045 |
| 46 | MP0005248_abnormal_Harderian_gland | 1.34807753 |
| 47 | MP0002822_catalepsy | 1.34662663 |
| 48 | MP0004885_abnormal_endolymph | 1.33281887 |
| 49 | MP0005275_abnormal_skin_tensile | 1.30955090 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.29749704 |
| 51 | MP0001905_abnormal_dopamine_level | 1.27448739 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.27047482 |
| 53 | MP0001529_abnormal_vocalization | 1.26032810 |
| 54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.26020918 |
| 55 | MP0002066_abnormal_motor_capabilities/c | 1.23027840 |
| 56 | MP0003633_abnormal_nervous_system | 1.20405886 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.19658038 |
| 58 | MP0001984_abnormal_olfaction | 1.17102025 |
| 59 | MP0001299_abnormal_eye_distance/ | 1.13030627 |
| 60 | MP0000920_abnormal_myelination | 1.10406188 |
| 61 | MP0003879_abnormal_hair_cell | 1.09709764 |
| 62 | MP0001502_abnormal_circadian_rhythm | 1.07588945 |
| 63 | MP0005645_abnormal_hypothalamus_physiol | 1.03519068 |
| 64 | MP0004215_abnormal_myocardial_fiber | 1.02870736 |
| 65 | MP0004085_abnormal_heartbeat | 0.98652769 |
| 66 | MP0005535_abnormal_body_temperature | 0.97907007 |
| 67 | MP0003634_abnormal_glial_cell | 0.96325397 |
| 68 | MP0002234_abnormal_pharynx_morphology | 0.93083139 |
| 69 | MP0003631_nervous_system_phenotype | 0.92620037 |
| 70 | MP0005394_taste/olfaction_phenotype | 0.92331873 |
| 71 | MP0005499_abnormal_olfactory_system | 0.92331873 |
| 72 | MP0001944_abnormal_pancreas_morphology | 0.91439538 |
| 73 | MP0004484_altered_response_of | 0.91131980 |
| 74 | MP0005187_abnormal_penis_morphology | 0.90867842 |
| 75 | MP0005503_abnormal_tendon_morphology | 0.90430707 |
| 76 | MP0004742_abnormal_vestibular_system | 0.89559910 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.89147986 |
| 78 | MP0004142_abnormal_muscle_tone | 0.88500195 |
| 79 | MP0005253_abnormal_eye_physiology | 0.87618878 |
| 80 | MP0000604_amyloidosis | 0.87618108 |
| 81 | MP0002229_neurodegeneration | 0.87568839 |
| 82 | MP0005623_abnormal_meninges_morphology | 0.85981128 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 0.85951869 |
| 84 | MP0001664_abnormal_digestion | 0.85788544 |
| 85 | MP0000747_muscle_weakness | 0.85156879 |
| 86 | MP0000749_muscle_degeneration | 0.85139343 |
| 87 | MP0002152_abnormal_brain_morphology | 0.85010427 |
| 88 | MP0002069_abnormal_eating/drinking_beha | 0.84814513 |
| 89 | MP0002295_abnormal_pulmonary_circulatio | 0.83864883 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 0.83763886 |
| 91 | MP0004272_abnormal_basement_membrane | 0.82974287 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.82136831 |
| 93 | MP0001542_abnormal_bone_strength | 0.81616160 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 0.81486639 |
| 95 | MP0001188_hyperpigmentation | 0.80799819 |
| 96 | MP0005379_endocrine/exocrine_gland_phen | 0.80573594 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.79202070 |
| 98 | MP0004130_abnormal_muscle_cell | 0.78814419 |
| 99 | MP0004036_abnormal_muscle_relaxation | 0.78298421 |
| 100 | MP0000569_abnormal_digit_pigmentation | 0.77523869 |
| 101 | MP0000750_abnormal_muscle_regeneration | 0.77327998 |
| 102 | MP0002972_abnormal_cardiac_muscle | 0.77044299 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.76584982 |
| 104 | MP0002751_abnormal_autonomic_nervous | 0.76259639 |
| 105 | MP0002896_abnormal_bone_mineralization | 0.75853743 |
| 106 | MP0000049_abnormal_middle_ear | 0.74371222 |
| 107 | MP0002876_abnormal_thyroid_physiology | 0.74039517 |
| 108 | MP0000003_abnormal_adipose_tissue | 0.73934285 |
| 109 | MP0003011_delayed_dark_adaptation | 0.72300326 |
| 110 | MP0000462_abnormal_digestive_system | 0.71845409 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.70981334 |
| 112 | MP0005620_abnormal_muscle_contractility | 0.70895848 |
| 113 | MP0003890_abnormal_embryonic-extraembry | 0.70560316 |
| 114 | MP0002752_abnormal_somatic_nervous | 0.69502866 |
| 115 | MP0005551_abnormal_eye_electrophysiolog | 0.69324206 |
| 116 | MP0003195_calcinosis | 0.69279600 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.68286704 |
| 118 | MP0002090_abnormal_vision | 0.68190800 |
| 119 | MP0002877_abnormal_melanocyte_morpholog | 0.68014032 |
| 120 | MP0001177_atelectasis | 0.66950458 |
| 121 | MP0000026_abnormal_inner_ear | 0.66331070 |
| 122 | MP0003137_abnormal_impulse_conducting | 0.65982450 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.65464359 |
| 124 | MP0001879_abnormal_lymphatic_vessel | 0.65311698 |
| 125 | MP0003787_abnormal_imprinting | 0.65080566 |
| 126 | MP0001963_abnormal_hearing_physiology | 0.65063009 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.64256753 |
| 128 | MP0008874_decreased_physiological_sensi | 0.63853936 |
| 129 | MP0003690_abnormal_glial_cell | 0.63428656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.39753182 |
| 2 | Visual hallucinations (HP:0002367) | 4.47577827 |
| 3 | Myokymia (HP:0002411) | 4.30040901 |
| 4 | Atonic seizures (HP:0010819) | 4.19916040 |
| 5 | Focal seizures (HP:0007359) | 3.99105000 |
| 6 | Absence seizures (HP:0002121) | 3.56939207 |
| 7 | Neurofibrillary tangles (HP:0002185) | 3.51895642 |
| 8 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.51586790 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.47395325 |
| 10 | Epileptic encephalopathy (HP:0200134) | 3.29388248 |
| 11 | Pheochromocytoma (HP:0002666) | 3.23813253 |
| 12 | Split foot (HP:0001839) | 3.23699323 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.22785987 |
| 14 | Action tremor (HP:0002345) | 3.19767072 |
| 15 | Termporal pattern (HP:0011008) | 3.16164795 |
| 16 | Insidious onset (HP:0003587) | 3.16164795 |
| 17 | Dialeptic seizures (HP:0011146) | 3.06128949 |
| 18 | Gait imbalance (HP:0002141) | 3.03808550 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 2.98756134 |
| 20 | Hyperventilation (HP:0002883) | 2.97919292 |
| 21 | Progressive cerebellar ataxia (HP:0002073) | 2.97090870 |
| 22 | Neuroendocrine neoplasm (HP:0100634) | 2.93276326 |
| 23 | Agitation (HP:0000713) | 2.92723083 |
| 24 | Anxiety (HP:0000739) | 2.89290124 |
| 25 | Shoulder girdle muscle weakness (HP:0003547) | 2.75777215 |
| 26 | Papilledema (HP:0001085) | 2.70138963 |
| 27 | Depression (HP:0000716) | 2.67136345 |
| 28 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.66914907 |
| 29 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.66914907 |
| 30 | Congenital primary aphakia (HP:0007707) | 2.65708765 |
| 31 | Medial flaring of the eyebrow (HP:0010747) | 2.65696282 |
| 32 | Amyotrophic lateral sclerosis (HP:0007354) | 2.64754488 |
| 33 | Broad-based gait (HP:0002136) | 2.61699557 |
| 34 | Failure to thrive in infancy (HP:0001531) | 2.54084137 |
| 35 | Dysmetria (HP:0001310) | 2.51852573 |
| 36 | Amblyopia (HP:0000646) | 2.50714362 |
| 37 | Truncal ataxia (HP:0002078) | 2.49114917 |
| 38 | Poor suck (HP:0002033) | 2.46384375 |
| 39 | Febrile seizures (HP:0002373) | 2.46333081 |
| 40 | Excessive salivation (HP:0003781) | 2.45738497 |
| 41 | Drooling (HP:0002307) | 2.45738497 |
| 42 | Rimmed vacuoles (HP:0003805) | 2.45126364 |
| 43 | Scanning speech (HP:0002168) | 2.40832869 |
| 44 | Nephrogenic diabetes insipidus (HP:0009806) | 2.40293165 |
| 45 | Ankle clonus (HP:0011448) | 2.37783305 |
| 46 | Exercise-induced muscle cramps (HP:0003710) | 2.36315386 |
| 47 | Megalencephaly (HP:0001355) | 2.35601074 |
| 48 | Retinal dysplasia (HP:0007973) | 2.29542837 |
| 49 | Epileptiform EEG discharges (HP:0011182) | 2.29533806 |
| 50 | Dysdiadochokinesis (HP:0002075) | 2.29394853 |
| 51 | Progressive inability to walk (HP:0002505) | 2.28523136 |
| 52 | Poor eye contact (HP:0000817) | 2.28169254 |
| 53 | Abnormality of the corticospinal tract (HP:0002492) | 2.27475426 |
| 54 | Intention tremor (HP:0002080) | 2.22727242 |
| 55 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.21159943 |
| 56 | EEG with generalized epileptiform discharges (HP:0011198) | 2.20339507 |
| 57 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.19738910 |
| 58 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.19036517 |
| 59 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.19036517 |
| 60 | Limb-girdle muscle weakness (HP:0003325) | 2.18908427 |
| 61 | Abnormal eating behavior (HP:0100738) | 2.14590822 |
| 62 | Abnormal social behavior (HP:0012433) | 2.14496964 |
| 63 | Impaired social interactions (HP:0000735) | 2.14496964 |
| 64 | Delayed gross motor development (HP:0002194) | 2.13719604 |
| 65 | Limb dystonia (HP:0002451) | 2.12785810 |
| 66 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.12097717 |
| 67 | Pelvic girdle muscle weakness (HP:0003749) | 2.09943743 |
| 68 | Hypsarrhythmia (HP:0002521) | 2.09119973 |
| 69 | Postural tremor (HP:0002174) | 2.08907887 |
| 70 | Abnormality of the lower motor neuron (HP:0002366) | 2.06695022 |
| 71 | Mutism (HP:0002300) | 2.05069842 |
| 72 | Ventricular fibrillation (HP:0001663) | 2.04649308 |
| 73 | Papillary thyroid carcinoma (HP:0002895) | 2.04587206 |
| 74 | Muscular hypotonia of the trunk (HP:0008936) | 2.03549363 |
| 75 | Genital tract atresia (HP:0001827) | 2.02611315 |
| 76 | Cortical dysplasia (HP:0002539) | 2.02328233 |
| 77 | Limb-girdle muscle atrophy (HP:0003797) | 2.02282352 |
| 78 | Hyperthyroidism (HP:0000836) | 2.01642500 |
| 79 | Buphthalmos (HP:0000557) | 2.01160009 |
| 80 | Spastic gait (HP:0002064) | 2.01093403 |
| 81 | Type II lissencephaly (HP:0007260) | 2.01087184 |
| 82 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.00987755 |
| 83 | Genetic anticipation (HP:0003743) | 2.00613269 |
| 84 | Vaginal atresia (HP:0000148) | 2.00139792 |
| 85 | Ulnar claw (HP:0001178) | 1.99200247 |
| 86 | Hypoventilation (HP:0002791) | 1.98895911 |
| 87 | Rapidly progressive (HP:0003678) | 1.98447887 |
| 88 | Hypercortisolism (HP:0001578) | 1.97610739 |
| 89 | Urinary urgency (HP:0000012) | 1.97375104 |
| 90 | Specific learning disability (HP:0001328) | 1.97307082 |
| 91 | Spastic tetraplegia (HP:0002510) | 1.96632413 |
| 92 | Exotropia (HP:0000577) | 1.94857796 |
| 93 | Increased circulating renin level (HP:0000848) | 1.93830193 |
| 94 | Absent speech (HP:0001344) | 1.90695609 |
| 95 | Gaze-evoked nystagmus (HP:0000640) | 1.88927723 |
| 96 | Inability to walk (HP:0002540) | 1.88229081 |
| 97 | Psychosis (HP:0000709) | 1.87899507 |
| 98 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.86422176 |
| 99 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.86422176 |
| 100 | Torticollis (HP:0000473) | 1.86037565 |
| 101 | Akinesia (HP:0002304) | 1.85730337 |
| 102 | Postural instability (HP:0002172) | 1.83901174 |
| 103 | Blue irides (HP:0000635) | 1.83863048 |
| 104 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.83602858 |
| 105 | Ankyloglossia (HP:0010296) | 1.83334576 |
| 106 | Clonus (HP:0002169) | 1.83097351 |
| 107 | Cerebral hemorrhage (HP:0001342) | 1.83089955 |
| 108 | Generalized myoclonic seizures (HP:0002123) | 1.82839641 |
| 109 | Prolonged QT interval (HP:0001657) | 1.82139667 |
| 110 | Ketoacidosis (HP:0001993) | 1.81641436 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.77026351 |
| 112 | Delusions (HP:0000746) | 1.76444618 |
| 113 | Hypoglycemic coma (HP:0001325) | 1.76141365 |
| 114 | Hammertoe (HP:0001765) | 1.75297855 |
| 115 | Syncope (HP:0001279) | 1.74516713 |
| 116 | Congenital glaucoma (HP:0001087) | 1.73885360 |
| 117 | Focal dystonia (HP:0004373) | 1.73460168 |
| 118 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.73391290 |
| 119 | Bradykinesia (HP:0002067) | 1.70989212 |
| 120 | Hypothermia (HP:0002045) | 1.70694930 |
| 121 | Sensorimotor neuropathy (HP:0007141) | 1.70651179 |
| 122 | Abnormality of the calf musculature (HP:0001430) | 1.70152627 |
| 123 | Hyperparathyroidism (HP:0000843) | 1.69212911 |
| 124 | Prominent supraorbital ridges (HP:0000336) | 1.68798327 |
| 125 | Decreased circulating renin level (HP:0003351) | 1.68784768 |
| 126 | Lower limb muscle weakness (HP:0007340) | 1.67729153 |
| 127 | Hemiparesis (HP:0001269) | 1.67429721 |
| 128 | Pachygyria (HP:0001302) | 1.67073535 |
| 129 | Peripheral hypomyelination (HP:0007182) | 1.66863789 |
| 130 | Gait ataxia (HP:0002066) | 1.66508443 |
| 131 | Sudden death (HP:0001699) | 1.65952769 |
| 132 | Menstrual irregularities (HP:0000858) | 1.65645200 |
| 133 | Thickened helices (HP:0000391) | 1.65069656 |
| 134 | Craniofacial dystonia (HP:0012179) | 1.63931073 |
| 135 | Polyphagia (HP:0002591) | 1.63819696 |
| 136 | Stereotypic behavior (HP:0000733) | 1.63736533 |
| 137 | Abnormality of salivation (HP:0100755) | 1.63117973 |
| 138 | Premature rupture of membranes (HP:0001788) | 1.62724771 |
| 139 | Bronchomalacia (HP:0002780) | 1.61865077 |
| 140 | Methylmalonic acidemia (HP:0002912) | 1.61580303 |
| 141 | Metaphyseal dysplasia (HP:0100255) | 1.61505604 |
| 142 | Abnormal EKG (HP:0003115) | 1.61037554 |
| 143 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.59162526 |
| 144 | Esotropia (HP:0000565) | 1.58920357 |
| 145 | Hand muscle atrophy (HP:0009130) | 1.57951791 |
| 146 | Heterochromia iridis (HP:0001100) | 1.57879327 |
| 147 | Autoamputation (HP:0001218) | 1.57763919 |
| 148 | Ankle contracture (HP:0006466) | 1.57294543 |
| 149 | Follicular hyperkeratosis (HP:0007502) | 1.56867638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.92214012 |
| 2 | EPHA4 | 3.33790470 |
| 3 | TRIM28 | 2.96229364 |
| 4 | MAP3K9 | 2.92921595 |
| 5 | MAP3K4 | 2.63116925 |
| 6 | MARK1 | 2.60525557 |
| 7 | TESK1 | 2.49412248 |
| 8 | NTRK1 | 2.44689768 |
| 9 | ERBB3 | 2.28830896 |
| 10 | EPHA3 | 2.25633274 |
| 11 | MAP3K12 | 2.24989700 |
| 12 | MINK1 | 2.22306420 |
| 13 | KSR2 | 2.15327313 |
| 14 | MAP2K7 | 2.13429492 |
| 15 | MAP3K2 | 2.07705917 |
| 16 | MAP2K4 | 1.95547708 |
| 17 | MAP4K2 | 1.93084843 |
| 18 | RIPK4 | 1.84510121 |
| 19 | PAK6 | 1.82904700 |
| 20 | PNCK | 1.67977109 |
| 21 | PRKD3 | 1.62741487 |
| 22 | STK39 | 1.62052188 |
| 23 | DAPK2 | 1.61425466 |
| 24 | OXSR1 | 1.59755731 |
| 25 | CASK | 1.54447756 |
| 26 | CAMKK2 | 1.54364545 |
| 27 | CDK19 | 1.53418231 |
| 28 | CSNK1G1 | 1.52075380 |
| 29 | WNK4 | 1.50049967 |
| 30 | TNIK | 1.48994535 |
| 31 | KSR1 | 1.48878052 |
| 32 | PLK2 | 1.43252699 |
| 33 | CDK5 | 1.40054832 |
| 34 | PAK3 | 1.37798515 |
| 35 | UHMK1 | 1.37507618 |
| 36 | GRK5 | 1.36074665 |
| 37 | FRK | 1.35760829 |
| 38 | ARAF | 1.33686956 |
| 39 | RET | 1.28255492 |
| 40 | NTRK2 | 1.27825863 |
| 41 | CAMKK1 | 1.27264891 |
| 42 | CAMK2B | 1.17074855 |
| 43 | FER | 1.17058851 |
| 44 | PHKG1 | 1.16665331 |
| 45 | PHKG2 | 1.16665331 |
| 46 | INSRR | 1.15877607 |
| 47 | MYLK | 1.15625073 |
| 48 | CAMK2A | 1.15325081 |
| 49 | DYRK2 | 1.11981597 |
| 50 | STK38L | 1.11024578 |
| 51 | NME1 | 1.10884591 |
| 52 | SCYL2 | 1.09284212 |
| 53 | MAPK13 | 1.08644957 |
| 54 | CSNK1G2 | 1.02224828 |
| 55 | CAMK2D | 0.95957730 |
| 56 | SIK3 | 0.95848075 |
| 57 | PTK2B | 0.94857944 |
| 58 | BCR | 0.93843063 |
| 59 | PRKCG | 0.91586638 |
| 60 | MAP3K1 | 0.89847388 |
| 61 | TYRO3 | 0.88708164 |
| 62 | FES | 0.88142825 |
| 63 | WNK1 | 0.86477686 |
| 64 | CDK14 | 0.85918330 |
| 65 | DMPK | 0.83565576 |
| 66 | MAP3K5 | 0.82434310 |
| 67 | PRKCE | 0.81658100 |
| 68 | FGFR2 | 0.79795159 |
| 69 | LATS2 | 0.79394195 |
| 70 | DAPK1 | 0.77809956 |
| 71 | PRKCH | 0.76021479 |
| 72 | DYRK3 | 0.75703491 |
| 73 | DYRK1B | 0.75137835 |
| 74 | PDGFRA | 0.75107873 |
| 75 | BCKDK | 0.74981327 |
| 76 | LMTK2 | 0.74079630 |
| 77 | WNK3 | 0.73230345 |
| 78 | RPS6KA4 | 0.72595511 |
| 79 | CAMK2G | 0.72190617 |
| 80 | STK11 | 0.72116876 |
| 81 | SGK223 | 0.69517769 |
| 82 | SGK494 | 0.69517769 |
| 83 | LIMK1 | 0.68367516 |
| 84 | CDK18 | 0.67667926 |
| 85 | OBSCN | 0.67265273 |
| 86 | PDPK1 | 0.67150434 |
| 87 | FGR | 0.66753287 |
| 88 | CDK15 | 0.66142953 |
| 89 | EPHB1 | 0.65462306 |
| 90 | LATS1 | 0.65437121 |
| 91 | DDR2 | 0.64740653 |
| 92 | SIK2 | 0.64325196 |
| 93 | PTK2 | 0.64091889 |
| 94 | MAPKAPK5 | 0.63635272 |
| 95 | BMPR2 | 0.62415732 |
| 96 | HIPK2 | 0.61337897 |
| 97 | RAF1 | 0.59563763 |
| 98 | STK38 | 0.59312421 |
| 99 | PIM2 | 0.58009785 |
| 100 | PDK2 | 0.57729526 |
| 101 | DYRK1A | 0.57361419 |
| 102 | TAOK1 | 0.56988153 |
| 103 | MAP2K1 | 0.56854292 |
| 104 | CSNK1G3 | 0.55696197 |
| 105 | ROCK2 | 0.54492666 |
| 106 | CDK11A | 0.53581110 |
| 107 | CAMK1 | 0.53393948 |
| 108 | MAP3K6 | 0.52834686 |
| 109 | NEK1 | 0.52121920 |
| 110 | CAMK1G | 0.51334006 |
| 111 | SRPK1 | 0.50300250 |
| 112 | SGK1 | 0.50073608 |
| 113 | TIE1 | 0.49989273 |
| 114 | PDK1 | 0.48783333 |
| 115 | PINK1 | 0.48248069 |
| 116 | PIK3CA | 0.47966352 |
| 117 | CSNK1A1L | 0.47413847 |
| 118 | ADRBK1 | 0.47050350 |
| 119 | MET | 0.46794725 |
| 120 | EPHB2 | 0.46073667 |
| 121 | GRK7 | 0.44031398 |
| 122 | PRKG1 | 0.43462223 |
| 123 | MARK2 | 0.43424036 |
| 124 | PKN1 | 0.43100339 |
| 125 | FYN | 0.43092570 |
| 126 | ABL2 | 0.42965205 |
| 127 | MAP3K13 | 0.42869706 |
| 128 | PRKACA | 0.42636176 |
| 129 | ROCK1 | 0.40678881 |
| 130 | CAMK4 | 0.39456100 |
| 131 | PRKCZ | 0.39412250 |
| 132 | PRKD1 | 0.35968512 |
| 133 | CSNK1A1 | 0.35754890 |
| 134 | PRKACB | 0.35111945 |
| 135 | MST4 | 0.30859120 |
| 136 | PRKACG | 0.30036954 |
| 137 | ERBB4 | 0.29836194 |
| 138 | PAK4 | 0.29537434 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.68884429 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.48218899 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.39474497 |
| 4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.22149728 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.20574952 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.20030585 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.16598839 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13710893 |
| 9 | Insulin secretion_Homo sapiens_hsa04911 | 2.06453720 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.01868876 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.01351232 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.89249390 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.78774045 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.75960197 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.73638272 |
| 16 | Renin secretion_Homo sapiens_hsa04924 | 1.68815062 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68762084 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67852378 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.64713065 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62690617 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62393746 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.61526916 |
| 23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59249701 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.57566519 |
| 25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.57549759 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.44813522 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42809818 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.37544276 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.26973640 |
| 30 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.25618164 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.25462416 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.22998193 |
| 33 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22933388 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.21972539 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21138031 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.20768571 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.19897848 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18660651 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.18046213 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.18019402 |
| 41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14719595 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13422248 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.13209173 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.12641621 |
| 45 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11510176 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 1.09737001 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.08522137 |
| 48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06729718 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06056010 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.04846223 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02978153 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.02312371 |
| 53 | Melanogenesis_Homo sapiens_hsa04916 | 1.01422221 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99519121 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.98817001 |
| 56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.97315793 |
| 57 | Glioma_Homo sapiens_hsa05214 | 0.96611311 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94982451 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.93111021 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 0.92390211 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90248939 |
| 62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90138958 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89576620 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88133287 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88006519 |
| 66 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83807485 |
| 67 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.83334740 |
| 68 | Protein export_Homo sapiens_hsa03060 | 0.83113647 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81682372 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81232903 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81065324 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78267110 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76866870 |
| 74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76835165 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.75235543 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74267351 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.70110890 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69747326 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69013242 |
| 80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68462760 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.68230025 |
| 82 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67037949 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66906395 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65214953 |
| 85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64387057 |
| 86 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63888745 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62829875 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59103786 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.58783664 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58744550 |
| 91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58468455 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58322901 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58131441 |
| 94 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56868911 |
| 95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56751373 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56661014 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.55144735 |
| 98 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54175943 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.53940165 |
| 100 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51412776 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51260969 |
| 102 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.51204601 |
| 103 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50928711 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.50385139 |
| 105 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.50079506 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49727387 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.49495481 |
| 108 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49443540 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49337579 |
| 110 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.47084554 |
| 111 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46981905 |
| 112 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46465724 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45016179 |
| 114 | Endocytosis_Homo sapiens_hsa04144 | 0.44893090 |
| 115 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44408144 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44404795 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43822434 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43217156 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43190468 |
| 120 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43121314 |
| 121 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42261463 |
| 122 | Phagosome_Homo sapiens_hsa04145 | 0.42080036 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.41948475 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41082730 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41037423 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.40922684 |
| 127 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40851498 |
| 128 | Alcoholism_Homo sapiens_hsa05034 | 0.40720367 |
| 129 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40430347 |
| 130 | Tight junction_Homo sapiens_hsa04530 | 0.40184046 |
| 131 | Phototransduction_Homo sapiens_hsa04744 | 0.40152889 |
| 132 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.40022626 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38580745 |
| 134 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37248908 |
| 135 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37208239 |
| 136 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.36656251 |
| 137 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35933318 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33897018 |

